调强放疗与三维适形放疗治疗胃癌的疗效与安全性:系统综述与荟萃分析
该系统综述与荟萃分析纳入9项对照临床研究共516例胃癌患者,比较调强放疗(IMRT)与三维适形放疗(3D-CRT)的疗效与安全性。结果显示IMRT组3年局部控制率显著高于3D-CRT组,3年总生存率略高但无统计学意义,3年无病生存率无显著差异,2-4级毒性相似。
要点
- IMRT组3年局部控制率显著高于3D-CRT组。
- 3年总生存率IMRT略高但无统计学意义。
- 2-4级毒性在IMRT与3D-CRT组间相似。
核心结论
- IMRT在胃癌治疗中可能优于3D-CRT,体现在局部控制率提高且不增加毒性。
研究设计与样本
- 系统综述与荟萃分析,检索Embase、PubMed、Cochrane Library及临床试验数据库,纳入9项对照临床研究共516例胃癌患者,使用Stata 14.0软件分析。
主要发现
- IMRT组3年总生存率略高于3D-CRT组,但无统计学显著性。
- IMRT组3年局部控制率显著高于3D-CRT组。
- IMRT组与3D-CRT组3年无病生存率无显著差异。
- IMRT组与3D-CRT组2-4级毒性相似。
临床怎么用
- 对于胃癌放疗患者,可考虑采用IMRT以改善局部控制且不增加毒性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Radiation or radiochemotherapy is a common adjuvant therapy for gastric cancer. Intensity-modulated radiation therapy (IMRT) has been demonstrated to provide better dose conformity, allowing dose escalation and/or reduction of normal tissue exposure compared with three-dimensional conformal radiation treatment (3D-CRT). However, the efficacy of IMRT and 3D-CRT in gastric cancer remains controversial. This study aimed to compare the efficacy and safety of IMRT with those of 3D-CRT in treating patients with gastric cancer through conducting a meta-analysis of 3-year survival rates [overall survival (OS) and disease-free survival (DFS)], local control rates, and toxic event rates. METHODS: Embase, PubMed, the Cochrane Library, and clinical trial databases were searched to identify the clinical trials of IMRT versus 3D-CRT for treating patients with gastric cancer. The obtained data of survival and safety were analyzed using the Stata 14.0 software. RESULTS: A total of 9 controlled clinical studies, including 516 patients with gastric cancer, met the inclusion criteria and were included in this meta-analysis. The results of the meta-analysis showed that the 3-year OS rate was slightly higher in the IMRT group than in the 3D-CRT group, without any statistical significance. The 3-year local control rate was significantly higher in the IMRT group than in the 3D-CRT group. No significant difference in the 3-year DFS rate was found between the IMRT and 3D-CRT groups. Grade 2-4 toxicities were similar between the IMRT and 3D-CRT groups. CONCLUSION: The findings suggested that IMRT might be superior to 3D-CRT in treating patients with gastric cancer in terms of local control rates without increasing toxicity.
引用
- Ren F, Li S, Zhang Y, et al. Efficacy and safety of intensity-modulated radiation therapy versus three-dimensional conformal radiation treatment for patients with gastric cancer: a systematic review and meta-analysis. Radiat Oncol. 2019. PMID: 31118042. doi:10.1186/s13014-019-1294-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。